Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chi

Showing results (351-360 of 410) with videos related to

Pageof 41
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 21, 2024
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forumFred Saad, Sebastien J Hotte, Krista Noonan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Neoadjuvant Enzalutamide Prior to ProstatectomyBruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
Pediatric Blood & Cancer|October 15, 2013
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancerNathan J Robison, Federico Campigotto, Susan N Chi, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)H-M Lin, T Scheinberg, N Portman, et al.
Oncogene|September 29, 2015
INPP4B is an oncogenic regulator in human colon cancerS T Guo, M N Chi, R H Yang, et al.
Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate CancerSusan Halabi, William Kevin Kelly, Hua Ma, et al.
JCO Precision Oncology|September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort AnalysisAnuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.
British Journal of Cancer|February 12, 2026
Paediatric Therapeutic Development Workshop on rhabdoid tumoursClaudia Montiel Equihua, Jan J Molenaar, Itziar Areso, et al.
Pageof 41

Showing results (351-360 of 410) with videos related to

Sort By:
Pageof 41
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 21, 2024
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forumFred Saad, Sebastien J Hotte, Krista Noonan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Neoadjuvant Enzalutamide Prior to ProstatectomyBruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
Pediatric Blood & Cancer|October 15, 2013
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancerNathan J Robison, Federico Campigotto, Susan N Chi, et al.
The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2025
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)H-M Lin, T Scheinberg, N Portman, et al.
Oncogene|September 29, 2015
INPP4B is an oncogenic regulator in human colon cancerS T Guo, M N Chi, R H Yang, et al.
Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate CancerSusan Halabi, William Kevin Kelly, Hua Ma, et al.
JCO Precision Oncology|September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort AnalysisAnuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.
British Journal of Cancer|February 12, 2026
Paediatric Therapeutic Development Workshop on rhabdoid tumoursClaudia Montiel Equihua, Jan J Molenaar, Itziar Areso, et al.
Pageof 41